Efficacy and Safety Study of Lucentis (Ranibizumab) and Visudyne (Verteporfin) Combination Therapy in Neovascular AMD - Related Studies

Efficacy and Safety Study of Lucentis (Ranibizumab) and Visudyne (Verteporfin) Combination Therapy in Neovascular AMD (Luvi)

This study has been completed.

Study NCT00574093 Information provided by Fondazione G.B. Bietti, IRCCS

First Received: December 13, 2007 Last Updated: October 29, 2009 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Additional conditions recognized in this trial

Macular Degeneration

More general conditions related to this trial

Interventions listed in this trial

Additional drug interventions recognized in this trial

Verteporfin

More general drug interventions related to this trial

Sponsors listed in this trial